Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerardo Z Lederkremer

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Current Opinion in Structural Biology|July 21, 2009
Glycoprotein folding, quality control and ER-associated degradationGerardo Z Lederkremer
Microscopy (Oxford, England)|September 3, 2016
Common fixation-permeabilization methods cause artifactual localization of a type II transmembrane proteinRon Benyair, Gerardo Z Lederkremer
Trends in Biochemical Sciences|May 29, 2019
Compartmentalization and Selective Tagging for Disposal of Misfolded GlycoproteinsMarina Shenkman, Gerardo Z Lederkremer
Trends in Biochemical Sciences|June 14, 2005
A window of opportunity: timing protein degradation by trimming of sugars and ubiquitinsGerardo Z Lederkremer, Michael H Glickman
Biomolecules|March 3, 2021
PERK Pathway and Neurodegenerative Disease: To Inhibit or to Activate?Talya Shacham, Chaitanya Patel, Gerardo Z Lederkremer
Frontiers in Molecular Biosciences|April 20, 2019
Protein Misfolding and ER Stress in Huntington's DiseaseTalya Shacham, Neeraj Sharma, Gerardo Z Lederkremer
Cell Stress & Chaperones|January 31, 2008
ER stress induces alternative nonproteasomal degradation of ER proteins but not of cytosolic onesMarina Shenkman, Sandra Tolchinsky, Gerardo Z Lederkremer
International Review of Cell and Molecular Biology|November 15, 2011
Protein quality control, retention, and degradation at the endoplasmic reticulumRon Benyair, Efrat Ron, Gerardo Z Lederkremer
The Journal of Biological Chemistry|November 3, 2019
Letting go of <i>O</i>-glycansHaddas Saad, Chaitanya Patel, Gerardo Z Lederkremer
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 17, 2024
Efficacy of therapy by MK-28 PERK activation in the Huntington's disease R6/2 mouse modelTalya Shacham, Daniel Offen, Gerardo Z Lederkremer
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Current Opinion in Structural Biology|July 21, 2009
Glycoprotein folding, quality control and ER-associated degradationGerardo Z Lederkremer
Microscopy (Oxford, England)|September 3, 2016
Common fixation-permeabilization methods cause artifactual localization of a type II transmembrane proteinRon Benyair, Gerardo Z Lederkremer
Trends in Biochemical Sciences|May 29, 2019
Compartmentalization and Selective Tagging for Disposal of Misfolded GlycoproteinsMarina Shenkman, Gerardo Z Lederkremer
Trends in Biochemical Sciences|June 14, 2005
A window of opportunity: timing protein degradation by trimming of sugars and ubiquitinsGerardo Z Lederkremer, Michael H Glickman
Biomolecules|March 3, 2021
PERK Pathway and Neurodegenerative Disease: To Inhibit or to Activate?Talya Shacham, Chaitanya Patel, Gerardo Z Lederkremer
Frontiers in Molecular Biosciences|April 20, 2019
Protein Misfolding and ER Stress in Huntington's DiseaseTalya Shacham, Neeraj Sharma, Gerardo Z Lederkremer
Cell Stress & Chaperones|January 31, 2008
ER stress induces alternative nonproteasomal degradation of ER proteins but not of cytosolic onesMarina Shenkman, Sandra Tolchinsky, Gerardo Z Lederkremer
International Review of Cell and Molecular Biology|November 15, 2011
Protein quality control, retention, and degradation at the endoplasmic reticulumRon Benyair, Efrat Ron, Gerardo Z Lederkremer
The Journal of Biological Chemistry|November 3, 2019
Letting go of <i>O</i>-glycansHaddas Saad, Chaitanya Patel, Gerardo Z Lederkremer
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 17, 2024
Efficacy of therapy by MK-28 PERK activation in the Huntington's disease R6/2 mouse modelTalya Shacham, Daniel Offen, Gerardo Z Lederkremer
Pageof 4